Brigatinib is this inhibitor that’s meant for folks with an ALK-positive kind of cancer called NSCLC, which has spread. It stops the whole thing by blocking that ALK pathway. It comes in pills in 30, 90, or 180 milligram sizes.
You should start with 90 mg every day for the first week, then switch to 180 mg daily. Each bottle holds 30 pills.
Reviews
There are no reviews yet.